Inventors: S Murugesan

The process of discovery, along with subsequent biological evaluation, has led to the identification of innovative compounds that exhibit dual inhibitory activity against both DprE1 and InhA enzymes. These compounds are being investigated for their potential as effective anti-tubercular agents, demonstrating promise in the fight against tuberculosis.